FC
WST icon

FORA Capital’s West Pharmaceutical WST Stock Holding History

FORA Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,520
Closed -$1.21M – 693
2025
Q2 		$1.21M Buy
+5,520
New +$1.18M 0.13% 190
2024
Q4 		– Sell
-8,498
Closed -$2.55M – 622
2024
Q3 		$2.55M Buy
8,498
+7,789
+1,099% +$2.39M 0.3% 98
2024
Q2 		$234K Buy
+709
New +$251K 0.03% 341
2024
Q1 		– Sell
-6,837
Closed -$2.41M – 590
2023
Q4 		$2.41M Buy
6,837
+3,928
+135% +$1.39M 0.21% 135
2023
Q3 		$1.09M Sell
2,909
-5,917
-67% -$2.29M 0.1% 235
2023
Q2 		$3.38M Buy
+8,826
New +$3.15M 0.48% 63
2022
Q3 		– Sell
-4,298
Closed -$1.3M – 605
2022
Q2 		$1.3M Buy
4,298
+3,688
+605% +$1.2M 0.26% 125
2022
Q1 		$255K Buy
610
+149
+32% +$58.3K 0.05% 428
2021
Q4 		$216K Sell
461
-200
-30% -$86.1K 0.08% 280
2021
Q3 		$281K Sell
661
-1,486
-69% -$626K 0.07% 290
2021
Q2 		$771K Buy
2,147
+1,596
+290% +$527K 0.14% 182
2021
Q1 		$155K Buy
+551
New +$158K 0.05% 331
2020
Q2 		– Sell
-6,001
Closed -$914K – 1363
2020
Q1 		$914K Buy
6,001
+3,333
+125% +$513K 0.2% 135
2019
Q4 		$401K Buy
+2,668
New +$388K 0.04% 448

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

FORA Capital's WST Position: Q3 2025 in Review

FORA Capital sold out of West Pharmaceutical (WST) in Q3 2025, closing a stake of 5,520 shares — an estimated $1.21M sold.

FORA Capital first reported a position in WST in Q4 2019 and held it in 14 quarters. The position peaked at $3.38M in Q2 2023. 758 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • FORA Capital reported no remaining West Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • FORA Capital sold 5,520 West Pharmaceutical shares in Q3 2025, an estimated $1.21M.
  • FORA Capital first reported a position in West Pharmaceutical in Q4 2019 and held it in 14 quarters.
  • FORA Capital's West Pharmaceutical position peaked at $3.38M in Q2 2023.
  • 758 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on FORA Capital's 13F filing for Q3 2025, filed 13 Nov 2025.